These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2302230

  • 1. The homologous restriction factor is immunologically related to complement components C8 and C9 and to lymphocyte pore-forming protein perforin through cysteine-rich domains.
    Young JD, Rosse WF, Hasselkus-Light CS.
    Biochem Biophys Res Commun; 1990 Jan 30; 166(2):648-52. PubMed ID: 2302230
    [Abstract] [Full Text] [Related]

  • 2. Anti-idiotypic antibodies derived against C8, C9 and perforin bind homologous restriction factor.
    Young JD, Jiang S, Liu CC, Hasselkus-Light CS.
    J Immunol Methods; 1990 Mar 27; 128(1):133-42. PubMed ID: 1691232
    [Abstract] [Full Text] [Related]

  • 3. The pore-forming protein (perforin) of cytolytic T lymphocytes is immunologically related to the components of membrane attack complex of complement through cysteine-rich domains.
    Young JD, Liu CC, Leong LG, Cohn ZA.
    J Exp Med; 1986 Dec 01; 164(6):2077-82. PubMed ID: 3537195
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Homologous restriction factor: effect on complement C8 and C9 uptake and lysis.
    Zalman LS, Müller-Eberhard H.
    Mol Immunol; 1994 Mar 01; 31(4):301-5. PubMed ID: 8139583
    [Abstract] [Full Text] [Related]

  • 9. Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor.
    Tschopp J, Mollnes TE.
    Proc Natl Acad Sci U S A; 1986 Jun 01; 83(12):4223-7. PubMed ID: 2424021
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
    Hänsch GM, Schönermark S, Roelcke D.
    J Clin Invest; 1987 Jul 01; 80(1):7-12. PubMed ID: 3597779
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor.
    Schönermark S, Rauterberg EW, Shin ML, Löke S, Roelcke D, Hänsch GM.
    J Immunol; 1986 Mar 01; 136(5):1772-6. PubMed ID: 2419413
    [Abstract] [Full Text] [Related]

  • 15. Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysis.
    Meri S, Morgan BP, Wing M, Jones J, Davies A, Podack E, Lachmann PJ.
    J Exp Med; 1990 Jul 01; 172(1):367-70. PubMed ID: 1694224
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
    Jiang S, Persechini PM, Perussia B, Young JD.
    J Immunol; 1989 Sep 01; 143(5):1453-60. PubMed ID: 2503557
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.